Aura Biosciences, Inc.
AURA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $48 | $107 | $38 | $32 |
| Short-Term Investments | $114 | $70 | $90 | $119 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $8 | $7 | $7 | $10 |
| Total Curr. Assets | $170 | $184 | $135 | $161 |
| Property Plant & Equip (Net) | $19 | $19 | $20 | $21 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $1 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $0 | $1 | $1 |
| Total NC Assets | $20 | $20 | $21 | $22 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $190 | $204 | $155 | $183 |
| Liabilities | – | – | – | – |
| Payables | $2 | $1 | $2 | $2 |
| Short-Term Debt | $3 | $3 | $3 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $14 | $10 | $7 | $9 |
| Total Curr. Liab. | $19 | $15 | $12 | $15 |
| LT Debt | $15 | $15 | $15 | $16 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $15 | $15 | $15 | $16 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $18 | $18 | $18 | $19 |
| Total Liabilities | $33 | $30 | $27 | $31 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$455 | -$429 | -$402 | -$374 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $611 | $603 | $530 | $526 |
| Total Equity | $157 | $175 | $128 | $152 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $190 | $204 | $155 | $183 |
| Net Debt | -$30 | -$89 | -$20 | -$13 |